The Gaithersburg-based company will first appear at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, at 9:45 a.m. EDT. Following this, leadership moves to the Citi 2026 BioPharma Back to School Conference on Thursday, September 10, at 10:00 a.m. EDT. Both sessions will be accessible to the public via live webcasts hosted on the investor relations section of the Novavax website, with archived replays remaining available for 30 days post-event.

Novavax continues to center its corporate strategy on three pillars: technology partnerships, capital-efficient innovation, and a streamlined operating model. These appearances arrive as the company balances the commercialization of its Nuvaxovid and R21/Matrix-M vaccines with the broader application of its protein-based nanoparticle technology.